Redcare Pharmacy NV (RDC)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 77.90 |
|---|---|
| 52-week range | 30.20 – 82.55 |
| Return, 1 month / 3 months | +26.7% / +18.5% |
| Return, 1 year / 3 years | −2.0% / −27.8% |
| Trend | Uptrend |
| RSI (14) | 63 |
| Volatility (1 year) | 63.0% |
| Worst drawdown (1 year) | -61.0% |
| Average daily value traded | 5.53M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Redcare Pharmacy operates online pharmacies that supply medicines, health products and everyday pharmacy items to customers, chiefly in Germany and other European countries. Its business centres on the Shop Apotheke and Redcare brands, which let people order prescription and over-the-counter medicines and related health goods for delivery. The company is based in the Netherlands and serves consumers directly through its websites and apps, working with pharmacists and health partners to handle orders and advice.
On this site Redcare Pharmacy NV appears as a stock on the XETRA Stock Exchange (Germany), code RDC, with prices in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Redcare Pharmacy NV (RDC) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 77.90 on 23 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 209 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 2.0% and over the last three months it rose 18.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 91 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 35.8% | ||
| From 52-week high | -3.2% | ||
| Momentum | 69 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 18.5% | ||
| 6-month return | 56.7% | ||
| 12-month return, skipping the last month | -22.6% | ||
| Stability (higher is calmer) | 12 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 63.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -61.0% | ||
| Liquidity | 87 · Strong | Trades actively. | |
| Average daily value traded | 5.53M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +4.1% |
|---|---|
| 1 month | +26.7% |
| 3 months | +18.5% |
| 6 months | +56.7% |
| 1 year | −2.0% |
| 3 years | −27.8% |
| 5 years | −44.4% |
Signals
| 50-day / 200-day average | 64.96 / 57.37 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.43 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.